Daxor Return on Tangible Equity 2010-2011 | DXR
Current and historical return on tangible equity values for Daxor (DXR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Daxor Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2011-12-31 | $-0.01B | $0.04B | -14.46% |
| 2011-09-30 | $-0.00B | $0.04B | -6.78% |
| 2011-06-30 | $0.00B | $0.05B | 8.56% |
| 2011-03-31 | $0.00B | $0.05B | 8.70% |
| 2010-12-31 | $0.01B | $0.05B | 10.81% |
| 2010-09-30 | $0.00B | $0.05B | 4.30% |
| 2010-06-30 | $0.00B | $0.04B | 4.26% |
| 2010-03-31 | $0.01B | $0.05B | 16.84% |
| 2009-12-31 | $0.01B | $0.05B | 13.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.037B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.446B | 0.00 |
| Quest Diagnostics (DGX) | United States | $18.204B | 18.28 |
| DaVita (DVA) | United States | $14.448B | 18.68 |
| Encompass Health (EHC) | United States | $10.001B | 23.58 |
| Chemed (CHE) | United States | $8.458B | 25.99 |
| Elanco Animal Health (ELAN) | United States | $5.947B | 14.15 |
| Option Care Health (OPCH) | United States | $5.262B | 24.93 |
| RadNet (RDNT) | United States | $4.847B | 107.33 |
| LifeStance Health (LFST) | United States | $3.050B | 0.00 |
| Amedisys (AMED) | United States | $3.030B | 21.56 |
| Addus HomeCare (ADUS) | United States | $2.270B | 26.63 |
| Astrana Health (ASTH) | United States | $2.074B | 28.36 |
| U.S Physical Therapy (USPH) | United States | $1.339B | 35.20 |
| Pennant (PNTG) | United States | $0.909B | 36.76 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.889B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.260B | 0.00 |
| Bioqual (BIOQ) | United States | $0.055B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |